LYPD1 (LY6/PLAUR domain containing 1)

2014-11-01  

Identity

HGNC
LOCATION
2q21.2
LOCUSID
ALIAS
LYPDC1,PHTS
FUSION GENES

Other Information

Locus ID:

NCBI: 116372
MIM: 610450
HGNC: 28431
Ensembl: ENSG00000150551

Variants:

dbSNP: 116372
ClinVar: 116372
TCGA: ENSG00000150551
COSMIC: LYPD1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000150551ENST00000345008Q8N2G4
ENSG00000150551ENST00000397463Q8N2G4
ENSG00000150551ENST00000449209F8WD77

Expression (GTEx)

0
5
10
15
20
25
30

Pathways

PathwaySourceExternal ID
Metabolism of proteinsREACTOMER-HSA-392499
Post-translational protein modificationREACTOMER-HSA-597592
Post-translational modification: synthesis of GPI-anchored proteinsREACTOMER-HSA-163125

References

Pubmed IDYearTitleCitations
327729182020ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1.120
327729182020ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1.120
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
203796142010Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.78
164130182006PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.6
164130182006PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.6

Citation

Dessen P

LYPD1 (LY6/PLAUR domain containing 1)

Atlas Genet Cytogenet Oncol Haematol. 2014-11-01

Online version: http://atlasgeneticsoncology.org/gene/68716/js/lib/favicon/favicon-32x32.png